全文获取类型
收费全文 | 7024篇 |
免费 | 316篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 132篇 |
妇产科学 | 65篇 |
基础医学 | 783篇 |
口腔科学 | 161篇 |
临床医学 | 433篇 |
内科学 | 1483篇 |
皮肤病学 | 203篇 |
神经病学 | 796篇 |
特种医学 | 419篇 |
外科学 | 1173篇 |
综合类 | 31篇 |
预防医学 | 254篇 |
眼科学 | 201篇 |
药学 | 654篇 |
中国医学 | 9篇 |
肿瘤学 | 527篇 |
出版年
2022年 | 77篇 |
2021年 | 110篇 |
2020年 | 66篇 |
2019年 | 86篇 |
2018年 | 89篇 |
2017年 | 90篇 |
2016年 | 99篇 |
2015年 | 126篇 |
2014年 | 156篇 |
2013年 | 191篇 |
2012年 | 286篇 |
2011年 | 353篇 |
2010年 | 203篇 |
2009年 | 168篇 |
2008年 | 310篇 |
2007年 | 300篇 |
2006年 | 316篇 |
2005年 | 303篇 |
2004年 | 327篇 |
2003年 | 355篇 |
2002年 | 330篇 |
2001年 | 249篇 |
2000年 | 280篇 |
1999年 | 242篇 |
1998年 | 106篇 |
1997年 | 89篇 |
1996年 | 59篇 |
1995年 | 60篇 |
1994年 | 55篇 |
1993年 | 61篇 |
1992年 | 182篇 |
1991年 | 170篇 |
1990年 | 157篇 |
1989年 | 144篇 |
1988年 | 135篇 |
1987年 | 118篇 |
1986年 | 107篇 |
1985年 | 117篇 |
1984年 | 83篇 |
1983年 | 58篇 |
1982年 | 33篇 |
1979年 | 58篇 |
1978年 | 34篇 |
1977年 | 37篇 |
1975年 | 31篇 |
1974年 | 41篇 |
1973年 | 31篇 |
1971年 | 29篇 |
1968年 | 29篇 |
1967年 | 28篇 |
排序方式: 共有7376条查询结果,搜索用时 31 毫秒
131.
Naoki Ishiguro Takashi Nozawa Akiko Tsujihata Asami Saito Wataru Kishimoto Kazutoshi Yokoyama Takafumi Yotsumoto Kenji Sakai Takashi Igarashi Ikumi Tamai 《Drug metabolism and disposition》2004,32(5):519-524
We investigated influx and efflux transporters involved in blood-brain barrier transport of the nonsedative H1-antagonist epinastine. The basal-to-apical transport of [14C]epinastine was markedly higher than that in the opposite direction in LLC-GA5-COL150 cells stably transfected with human multidrug resistance (MDR)1 gene. The brain-to-plasma concentration ratio of [14C]epinastine in mdr1a/b(-/-) mice was 3.2 times higher than that in wild-type mice. The uptake of both [3H]mepyramine and [14C]epinastine into immortalized rat brain capillary endothelial cells (RBEC)1 showed temperature and concentration dependence. The kinetic parameters, K(m), V(max), and uptake clearance (V(max)/K(m)), of the initial uptake of [3H]mepyramine and [14C]epinastine by RBEC1 were 150 microM, 41.8 nmol/min/mg protein, and 279 microl/min/mg protein for mepyramine and 10.0 mM, 339 nmol/min/mg protein, and 33.9 microl/min/mg protein for epinastine, respectively. The uptake of [3H]mepyramine and [14C]epinastine by RBEC1 was inhibited by organic cations such as quinidine, amantadine, and verapamil, but not by other organic cations, tetraethyl ammonium, guanidine, and carnitine. Organic anions such as benzoic acid, estrone-3-sulfate, taurocholate, and neutral digoxin were not inhibitory. Furthermore, some cationic H1 antagonists (chlorpheniramine, cyproheptadine, ketotifen, and desloratadine) inhibited the [3H]mepyramine and [14C]epinastine uptake into RBEC1. In conclusion, the present study demonstrated that the combination of efficient efflux transport by P-glycoprotein and poor uptake by the influx transporter, which is identical with that responsible for the uptake of mepyramine, account for the low brain distribution of epinastine. 相似文献
132.
133.
Novel PSTPIP1 gene mutation in pyoderma gangrenosum,acne and suppurative hidradenitis syndrome
下载免费PDF全文
![点击此处可从《The Journal of dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
134.
135.
Kyoko Kanno Masako Minami‐Hori Akemi Ishida‐Yamamoto Keiji Komura Kensuke Oikawa Naoyuki Miyokawa Hajime Iizuka 《The Journal of dermatology》2014,41(8):736-738
We report a 38‐year‐old male patient who presented with cutaneous lesions mimicking widespread discoid lupus erythematosus with high‐grade fever, arthralgia and lymphadenopathy. Additional lymph node and skin biopsies, however, revealed karyorrhectic debris without neutrophils and numerous CD68‐positive cells, a characteristic finding of Kikuchi's disease (KD). Comparing skin biopsies on different occasions, we could see different forms of histopathology. The histopathology of skin lesions of KD may vary during the clinical course, which may reflect the stage of the disease. 相似文献
136.
Demetrius M. Kokkinakis S. Clifford Schold Jr. Hiroki Hori Tsutomu Nobori 《Nutrition and cancer》2013,65(3):195-204
Depletion of plasma methionine is expected to inhibit or reverse growth of methionine‐dependent tumors; however, modulation of methionine and other sulfur amino acids is not a trivial task in experimental animals. l‐Methioninase from Pseudomonas putida at 1,000 U/kg causes acute reduction of plasma methionine by 80% in mice, but recovery occurs within 14 hours. Restriction of dietary choline and replacement of dietary methionine with homocystine results in 50% chronic reduction of plasma methionine. A >70% reduction can be accomplished with a diet deficient in methionine, homocystine, and choline, but ultimately this diet is lethal. Plasma methionine can be lowered to a steady state of <5 μM in mice with a combination of dietary restriction of methionine, homocysteine, and choline and synchronous treatments with intraperitoneal injections of 1,000 U/kg L‐methioninase and 25–50 mg/kg homocystine, each administered at 12‐hour intervals. Modulation of plasma methionine by this means causes no weight loss or pathologies in liver or pancreas, and it does not markedly alter levels of cysteine, homocysteine, or glutathione in plasma or in hepatic tissue. When this procedure is applied to athymic mice bearing human medulloblastoma (Daoy) tumors subcutaneously, tumor growth is inhibited. Methionine deprivation arrests mitosis by blocking the cell cycle in G2 and induces apoptosis. Tumor stasis was achieved in 100% of treated animals within 4 days of treatment, and regression was seen in one‐third of animals after a 10‐day period. These data strongly support the use of methionine‐depleting regimens for tumor treatments. 相似文献
137.
Aki Masuzawa Chikako Kiyotani Tomoo Osumi Yoko Shioda Kazutoshi Iijima Osamu Tomita Kazuhiko Nakabayashi Keisuke Oboki Kazuki Yasuda Hiromi Sakamoto Hitoshi Ichikawa Kenichiro Hata Teruhiko Yoshida Kenji Matsumoto Nobutaka Kiyokawa Tetsuya Mori 《European journal of haematology》2014,92(3):263-267
In addition to BCR, various rare fusion partners for the ABL1 gene have been reported in leukemia. We have identified the fusion gene SNX2‐ABL1 in a pediatric case of acute lymphoblastic leukemia (ALL), which has only once previously been reported in an adult patient. Cytogenetic analysis detected this fusion gene arising from a t(5;9)(q22;q34) translocation. ALL cells carrying a SNX2‐ABL1 fusion exhibited a BCR‐ABL1+ ALL‐like gene expression profile. The patient poorly responded to dasatinib but partially responded to imatinib. Treatment using tyrosine kinase inhibitors requires further investigation to optimize the genotype‐based treatment stratification for patients with SNX2‐ABL1 fusion. 相似文献
138.
139.
140.